Bismuth Potassium Citrate
Bismuth Potassium Citrate is a pharmaceutical drug with 31 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 18 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
27
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
18 of 18 finished
0.0%
0 ended early
4
trials recruiting
31
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Optimization of Minocycline for Helicobacter Pylori Rescue Treatment
Rescue Therapy for Helicobacter Pylori Infection
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
Doxycycline for Helicobacter Pylori Rescue Treatment
Rescue Therapy for Helicobacter Pylori Eradication Treatment
Clinical Trials (31)
Optimization of Minocycline for Helicobacter Pylori Rescue Treatment
Rescue Therapy for Helicobacter Pylori Infection
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
Doxycycline for Helicobacter Pylori Rescue Treatment
Rescue Therapy for Helicobacter Pylori Eradication Treatment
High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses
A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
A Study of Vonoprazan in Adults With Helicobacter Pylori
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial
Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori
The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori
Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
Helicobacter Pylori Eradication and Follow-up
Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients
Tetracycline Versus Doxycycline for HP Rescue Therapy
PPI-amoxicillin for H. Pylori Treatment
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 31